Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

AbbVie deepens immunology legacy in $10.9bn Apogee buyout

The multi-billion-dollar bid could further cement AbbVie’s leading position in the immunology space as competition heats up.

Annabel Kartal Allen

News

HLTH Europe 2026: enriching the patient journey with health technologies

Annabel Kartal Allen

News

Moderna’s mRNA flu vaccine passes FDA AdCom, review underway

Robert Barrie

News

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

News

Japan approves Sanofi’s Sarclisa combo for MM treatment

Features

How biotech executives are confronting the funding and regulatory shifts

News

Biopharma industry confidence at highest in years despite geopolitical headwinds

Features

ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain

Analysis

Analyst Comment

ADA26: retatrutide delivers unprecedented weight loss in Phase III TRIUMPH-1

GlobalData Healthcare

Features

Can AI predict the (regulatory) future?

Frankie Fattorini

Analyst Comment

EHA26: BMS touts positive multiple myeloma data for two pipeline candidates

GlobalData Healthcare

Analyst Comment

EHA26: J&J’s multiple myeloma therapies impress with new data

GlobalData Healthcare

Themes

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Strong systems that enable trust and governance are key to enabling the growth of AI technologies in drug development.

More themes

Partner Content

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

Partner Content

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

News

Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer

Partner Content

Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Nasal Polyps (Nasal Polyposis) and CRSwNP (Chronic Rhinosinusitis with Nasal Polyps): Market View, Current and Future Competitive Landscape

$3495.00

Chronic Kidney Disease: Epidemiology Report and Forecast to 2035

$9995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

HLTH Europe 2026: enriching the patient journey with health technologies

Moderna’s mRNA flu vaccine passes FDA AdCom, review underway

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

Japan approves Sanofi’s Sarclisa combo for MM treatment

How biotech executives are confronting the funding and regulatory shifts

Biopharma industry confidence at highest in years despite geopolitical headwinds

ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain

ADA26: retatrutide delivers unprecedented weight loss in Phase III TRIUMPH-1

Can AI predict the (regulatory) future?

EHA26: BMS touts positive multiple myeloma data for two pipeline candidates

EHA26: J&J’s multiple myeloma therapies impress with new data

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

New Drug Approvals and Their Contract Manufacture: 2026 Edition

State of the Biopharmaceutical Industry 2026 (Mid-Year Update) Edition

Bio/Pharmaceutical Outsourcing Report, May 2026

Nasal Polyps (Nasal Polyposis) and CRSwNP (Chronic Rhinosinusitis with Nasal Polyps): Market View, Current and Future Competitive Landscape

Chronic Kidney Disease: Epidemiology Report and Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

New Drug Approvals and Their Contract Manufacture: 2026 Edition

State of the Biopharmaceutical Industry 2026 (Mid-Year Update) Edition

Bio/Pharmaceutical Outsourcing Report, May 2026

Nasal Polyps (Nasal Polyposis) and CRSwNP (Chronic Rhinosinusitis with Nasal Polyps): Market View, Current and Future Competitive Landscape

Chronic Kidney Disease: Epidemiology Report and Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing